{"id":182491,"date":"2020-04-30T14:24:29","date_gmt":"2020-04-30T14:24:29","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=182491"},"modified":"2020-04-30T14:24:29","modified_gmt":"2020-04-30T14:24:29","slug":"remdesivir-tot-ce-trebuie-sa-stii-despre-medicamentul-pentru-covid-19-pe-care-sua-vrea-sa-l-autorizeze-de-urgenta-anuntul-companiei-gilead","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=182491","title":{"rendered":"Remdesivir. Tot ce trebuie s\u0103 \u015ftii despre medicamentul pentru Covid-19, pe care SUA vrea s\u0103-l autorizeze de urgen\u0163\u0103. Anun\u0163ul companiei Gilead"},"content":{"rendered":"<p>\n<span style=\"font-size: 12px;\">Compania farmaceutic\u0103 Gilead Science anun\u0163\u0103 c\u0103 medicamentul antiviral Remdesivir are rezultate pozitive pe pacien\u0163ii infecta\u0163i cu COVID-19<\/span><\/p>\n<p>\nPacien\u0163ii trata\u0163i cu Remdesivir \u00een primele 10 zile de la infec\u0163ie s-au recuperat mai repede dec\u00e2t cei c\u0103rora li s-a administrat tratamentul dup\u0103 10 zile de la infectare<br \/>\nPacien\u0163ii care au primit tratamentul pe baz\u0103 de Remdesivir pe o perioad\u0103 de 5 zile, rezultate similare cu pacien\u0163ii trata\u0163i 10 zile<\/p>\n<p>\nSUA se gr\u0103besc s\u0103 autorizeze Remdesivir ca tratament pentru COVID-19 dup\u0103 ce pacien\u0163ii testa\u0163i s-au recuperat rapid<br \/>\nRemdesivir, rezultate pozitive \u00een tratarea COVID-19<br \/>\nCompania farmaceutic\u0103 Gilead Science a anun\u0163at rezultatele fazei a treia a unui studiu clinic, care a presupus testarea medicamentului antiviral Remdesivir, pe perioade de 5 \u015fi 10 zile, pe pacien\u0163ii afla\u0163i \u00een stare grav\u0103 \u00een urma infect\u0103rii cu COVID-19.<\/p>\n<p>\n\u201eStudiul arat\u0103 c\u0103 unii pacien\u0163i pot fi trata\u0163i timp de doar 5 zile, ceea ce ar cre\u015fte num\u0103rul persoanelor care ar putea fi tratate cu Remdesivir. Acest lucru este important, mai ales \u00een contextul acestei pandemiei, \u00eentruc\u00e2t ajut\u0103 personalul medical \u015fi spitalele s\u0103 trateze mai mul\u0163i pacien\u0163i, care au nevoie urgent\u0103 de tratament\u201d, a declarat Merdad Parsey, medicul \u015fef al Gilead.<\/p>\n<p>\nCu toate acestea, Remdesivir nu este \u00eenc\u0103 autorizat sau aprobat la nivel global \u015fi \u00eenc\u0103 nu s-a demonstrat dac\u0103 este sigur sau eficient pentru tratarea pacen\u0163ilor infecta\u0163i cu COVID-19. Prin acest studiu, compania a dorit s\u0103 afle dac\u0103 tratamentul de 5 zile cu acest medicament are acelea\u015fi efecte ca tratamentul de 10 zile.&nbsp; Al doilea obiectiv al companiei a fost aflarea efectelor adverse ale tratamentului, astfel c\u0103 pacien\u0163ilor supu\u015fi test\u0103rii li s-a cerut s\u0103 observe evolu\u0163ia pneumoniei \u015fi al nivelului redus de oxigen, care nu necesita ventila\u0163ie la momentul ini\u0163ierii studiului. Potrivit acestora, pacien\u0163ii recupera\u0163i \u015fi externa\u0163i au fost cei care nu mai aveau nevoie de \u00eengrijire medical\u0103 sau de oxigen.<\/p>\n<p>\n<a href=\"https:\/\/www.mediafax.ro\/coronavirus\/remdesivir-tot-ce-trebuie-sa-stii-despre-medicamentul-pentru-covid-19-pe-care-sua-vrea-sa-l-autorizeze-de-urgenta-anuntul-companiei-gilead-19107886\">Cititi mai multe pe www.mediafax.ro<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Compania farmaceutic\u0103 Gilead Science anun\u0163\u0103 c\u0103 medicamentul antiviral Remdesivir are rezultate pozitive pe pacien\u0163ii infecta\u0163i cu COVID-19 Pacien\u0163ii trata\u0163i cu Remdesivir \u00een primele 10 zile de la infec\u0163ie s-au recuperat mai repede dec\u00e2t cei c\u0103rora li s-a administrat tratamentul dup\u0103 10 zile de la infectare Pacien\u0163ii care au primit tratamentul pe baz\u0103 de Remdesivir pe [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[272,408,12923],"class_list":["post-182491","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-companie","tag-pacienti","tag-tratament"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/182491","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=182491"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/182491\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=182491"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=182491"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=182491"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}